Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Follicum Details Clinical Progress Of Hair Growth Stimulating Product

Executive Summary

A side effect observed during preclinical studies of a potential heart drug is underpinning the development of a peptide that shows promise in restoring hair growth. Follicum AB CBO Gunnar Gårdemyr took time out during his busy partnering schedule at BIO-Europe Spring 2018 to update Scrip on the progress the company is making with FOL-005, which is currently in Phase I/II studies and available for out-licensing.






Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts